Category Archives: Current Affairs

The OK for Patients’ Return to Healthcare Needs Clear Signals From Trusted Sources

COVID-19 was a shock to the system unlike anything that had been anticipated. Even prior to the shutdown, health-perceptive people were starting to avoid public venues and there were declines in the numbers of people going out to eat at … Continue reading

Posted in COVID19, Current Affairs | Tagged , | Comments Off on The OK for Patients’ Return to Healthcare Needs Clear Signals From Trusted Sources

The Pharmaceutical-Biotech-Devices Industries Face a New World Post-Pandemic

There is going to be a time in the not too distant future, when the fuller picture of the healthcare impacts of COVID-19 come into sharper focus. When that happens, it is not likely to be pretty. In large part, … Continue reading

Posted in COVID19, Current Affairs, Pharma Industry Image | Tagged , , | Comments Off on The Pharmaceutical-Biotech-Devices Industries Face a New World Post-Pandemic

T-Minus COVID-19 – Impact of Pandemic on New Medicine Launches

As the coronavirus pandemic began to unfold, focus on the pharmaceutical and biotech sectors was on the most immediate and apparent concerns – the impact on the supply chain for drugs that are currently in the market and on the … Continue reading

Posted in Approval Announcements, COVID19, Current Affairs, Pharma Industry Image | Comments Off on T-Minus COVID-19 – Impact of Pandemic on New Medicine Launches

Principles for COVID-19 Healthcare Communications – 2 – The Virtual Medical Meeting

Virtually everyone is going virtual. Even in February, which seems like a very long time ago, many organizers began either postponing or canceling major conferences and meetings. This has included major medical meetings and given that large gatherings will be … Continue reading

Posted in Advisory Committee Prepapartion, Current Affairs | Comments Off on Principles for COVID-19 Healthcare Communications – 2 – The Virtual Medical Meeting

Impact of COVID-19 on Regulatory Enforcement and Approvals – Part 3 – FDA Adds Resources to Facilitate COVID-19 Research

With the COVID-19 impact making itself apparent on a daily basis as the numbers climb and organizations respond, the effects on the pharma and biotech sector also shifts. Yesterday FDA announced a new concentration of agency assets to be focused … Continue reading

Posted in Current Affairs, FDA Policy | Comments Off on Impact of COVID-19 on Regulatory Enforcement and Approvals – Part 3 – FDA Adds Resources to Facilitate COVID-19 Research